Search results
TD Cowen Raises BioNTech (NASDAQ:BNTX) Price Target to $98.00
ETF DAILY NEWS· 12 hours agoBioNTech (NASDAQ:BNTX – Free Report) had its price objective lifted by TD Cowen from $95.00 to $98.00 in a report published on Tuesday, Benzinga reports. The brokerage currently ...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 4 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Simply Wall St. via Yahoo Finance· 2 days agoInvestors in BioNTech SE (NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 4 days agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
What's Going With BioNTech Stock On Monday?
Benzinga· 4 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 2 hours agoNovavax struggled after its COVID-19 vaccine was delayed by manufacturing issues early in...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 4 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 5 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 4 days agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...